Vontobel Holding Ltd. Sells 2,000 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Vontobel Holding Ltd. cut its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 20.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,000 shares of the company’s stock after selling 2,000 shares during the quarter. Vontobel Holding Ltd.’s holdings in VanEck Pharmaceutical ETF were worth $651,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC raised its stake in VanEck Pharmaceutical ETF by 910.0% during the 4th quarter. International Assets Investment Management LLC now owns 27,502 shares of the company’s stock valued at $2,238,000 after buying an additional 24,779 shares during the last quarter. Investment Partners Asset Management Inc. bought a new position in VanEck Pharmaceutical ETF in the fourth quarter valued at about $354,000. Allworth Financial LP bought a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at about $28,000. Raymond James Financial Services Advisors Inc. increased its position in shares of VanEck Pharmaceutical ETF by 462.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 18,148 shares of the company’s stock valued at $1,477,000 after purchasing an additional 14,921 shares during the last quarter. Finally, CoreFirst Bank & Trust purchased a new position in shares of VanEck Pharmaceutical ETF in the third quarter worth approximately $76,000.

VanEck Pharmaceutical ETF Trading Up 0.9 %

Shares of NASDAQ PPH opened at $85.92 on Tuesday. VanEck Pharmaceutical ETF has a 12-month low of $74.05 and a 12-month high of $91.16. The firm has a market capitalization of $506.07 million, a price-to-earnings ratio of 20.57 and a beta of 0.72. The firm has a 50 day moving average of $88.75 and a 200 day moving average of $83.53.

VanEck Pharmaceutical ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, April 2nd were given a dividend of $0.5328 per share. The ex-dividend date of this dividend was Monday, April 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.